We assessed the prognostic value of TET1 in BLCA using GEPIA [31], revealing that patients with high TET1 expression exhibited inferior survival, thereby providing additional evidence supporting its pro-tumor role in BLCA (Sfig. The gene discussed is TET1; the disease is bladder transitional cell carcinoma.